✦ LIBER ✦

P-559 Epirubicin/Paclitaxel/Etoposide (EPE): phase I–II study in extensive-disease small-cell lung cancer (ED-SCLC)

✍ Scribed by Fabbri, Alessandro; Innocenti, Florio; Pennucci, Maria Cristina; Del Freo, Alfonso; Tibaldi, Carmelo; Russo, Francesca; Prochilo, Tiziana; Baldini, Editta

Book ID: 118572254
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 190 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)92526-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-558 Phase-II trial of topotecan and et

P-558 Phase-II trial of topotecan and etoposide in extensive disease small cell lung cancer (ED-SCLC)

✍ Reck, Martin; Buchholz, Erika; Groth, Gesine; Kaubitzsch, Sabine; Gatzemeier, Ul 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Etoposide-cisplatin (EP) versus four-dru

Etoposide-cisplatin (EP) versus four-drug combination etoposide-cisplatin-epirubicin-cyclophosphamide (PCDE) in extensive disease small cell lung cancer (ED-SCLC). A FNCLCC phase III multicentre study

✍ Pujol, J; Daures, J; Riviere, A; Quoix, E; Depierre, A; Breton, J.L; Lemarie, E; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

P-563 Phase I study of sequential topote

P-563 Phase I study of sequential topotecan-carboplatin-etoposide in patients with Extensive Disease Small Cell Lung Cancer (ED-SCLC)

✍ Miller, Antonius A.; Tucker, Robert; Lesser, Glenn; Case, Doug 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Randomized, phase II study of topotecan/

Randomized, phase II study of topotecan/paclitaxel versus cisplatin/etoposide in patients with untreated, extensive disease, small cell lung cancer (SCLC)

✍ H. Lena; J. Breton; W. Yu; K. Steppert; K. Lightcap; G. Ross; M. Lymboura 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Phase II study of oral etoposide and int

Phase II study of oral etoposide and intravenous paclitaxel in extensive-stage small cell lung cancer

✍ Perez, Edith A; Geoffroy, Francois J; Hillman, Shauna; Johnson, Elizabeth A; Far 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Cisplatin — Paclitaxel — Topotecan (CPT)

Cisplatin — Paclitaxel — Topotecan (CPT) weekly administration in chemo-naive or pretreated extensive disease small cell lung cancer (ED-SCLC). A SICOG Phase II study

✍ N. Panza; G. Frasci; P. Comella; G. Nicolella; M. Natale; D. Muci; S. Palmeri; P 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 156 KB